Rise Advisors »

Pliant Therapeutics shares owned by Rise Advisors

Quarter-by-quarter ownership of Pliant Therapeutics (PLRX) shares owned by Rise Advisors from 13F filings

Historical chart of Rise Advisors investment in Pliant Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Pliant Therapeutics held by Rise Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pliant Therapeutics by Rise Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.1k 740 1.48
2025-06-30 $858 740 1.16

More positions owned by Rise Advisors

Vanguard Growth Etf 0 (VUG)
Vanguard Value Etf 0 (VTV)
Vanguard Core Bond Etf 0 (VCRB)
Janus Henderson Mortgage-backed Securities Etf 0 (JMBS)
Fidelity Total Bond Etf 0 (FBND)
Janus Henderson Small/mid Cap Growth Alpha Etf 0 (JSMD)
Janus Henderson Short Duration Income Etf 0 (VNLA)
Ft Vest Laddered Moderate Buffer Etf 0 (BUFZ)
Financial Select Sector Spdr Fund 0 (XLF)
Industrial Select Sector Spdr Fund 0 (XLI)
Nvidia Corporation 0 (NVDA)
Microsoft Corp 0 (MSFT)
Apple 0 (AAPL)
Berkshire Hathaway Inc Del Cl B 0 (BRK.B)
Energy Select Sector Spdr Fund 0 (XLE)

View all positions for Rise Advisors

Top funds holding Pliant Therapeutics

Tang Capital Management
Woodline Partners
Point72 Asset Management
Morgan Stanley
Blue Owl Capital Holdings
Vanguard Group
Acadian Asset Management
Citadel Advisors
Jpmorgan Chase & Co
Redmile Group
BlackRock
UBS Group
Peapod Lane Capital
Two Sigma Advisers
Renaissance Technologies

View all funds holding Pliant Therapeutics